In healthy subjects, oral glucose triggers a stronger insulin secretion response than intravenous glucose because of the secretion of incretin from the gastrointestinal tract, known as the incretin effect. Clinically, incretin-based drugs include glucagon-like peptide 1 receptor agonists (GLP-1 RA) (such as liraglutide) and dipeptidyl peptidase 4 inhibitors (DPP-4i) (such as vildagliptin)
How long does the B12 injection take
Anuradha D, Reddy KV, Kumar TC, Neeraja S, Reddy PR, Reddanna P
Renal diseases As previously reported, enhanced eryptosis contributes to the pathophysiology of several clinical disorders
The alkaline pH-adapted skin barrier is disrupted severely by SLS-induced irritation
Combination of quinine, quinidine and cinchonine for the treatment of acute falciparum malaria: correlation with the susceptibility of Plasmodium falciparum to the cinchona alkaloids in vitro